Pathology of squamous cell carcinoma of the penis: back to square one
dc.contributor.author | Sanchez, Diego F | en |
dc.contributor.author | Oliveira, Pedro | en |
dc.date.accessioned | 2024-07-31T09:57:16Z | |
dc.date.available | 2024-07-31T09:57:16Z | |
dc.date.issued | 2024 | en |
dc.identifier.citation | Sanchez DF, Oliveira P. Pathology of Squamous Cell Carcinoma of the Penis: Back to Square One. The Urologic clinics of North America. 2024 Aug;51(3):313-25. | en |
dc.identifier.pmid | 38925734 | en |
dc.identifier.doi | 10.1016/j.ucl.2024.03.003 | en |
dc.identifier.uri | http://hdl.handle.net/10541/627112 | |
dc.description.abstract | The landscape of squamous cell carcinoma of the penis (SCC-P) has undergone a significant transformation since the new World Health Organization classification of genitourinary cancers and recent European Association of Urology/American Association of Clinical Oncology guidelines. These changes emphasize the necessity to categorize SCC-P into 2 groups based on its association with human papillomavirus (HPV) infection. This shift has major implications, considering that prior knowledge was derived from a mix of both groups. Given the distinct prognosis, treatment options, and staging systems observed for HPV-associated tumors in other body areas, the question now arises: will similar patterns emerge for SCC-P? | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/j.ucl.2024.03.003 | en |
dc.title | Pathology of squamous cell carcinoma of the penis: back to square one | en |
dc.type | Article | en |
dc.contributor.department | Translational Oncogenomics Group, Manchester Cancer Research Centre & CRUK-MI, Wilmslow Road, Manchester M20 4GJ, UK. Department of Pathology, Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK. | en |
dc.identifier.journal | The Urologic Clinics of North America | en |
dc.description.note | en] |